A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters on Sept. 27, 2013. Sprout Pharmaceuticals, the makers of the twice-rejected pill intended to boost libido in women, will make a third attempt this week at convincing regulators to approve the drug as the first prescription treatment for low sexual desire in women. A panel of FDA experts will discuss the drug at a public meeting Thursday before voting on whether to recommend its approval.
A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters on Sept. 27, 2013. Sprout Pharmaceuticals, the makers of the twice-rejected pill intended to boost libido in women, will make a third attempt this week at convincing regulators to approve the drug as the first prescription treatment for low sexual desire in women. A panel of FDA experts will discuss the drug at a public meeting Thursday before voting on whether to recommend its approval. Allen Breed AP
A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters on Sept. 27, 2013. Sprout Pharmaceuticals, the makers of the twice-rejected pill intended to boost libido in women, will make a third attempt this week at convincing regulators to approve the drug as the first prescription treatment for low sexual desire in women. A panel of FDA experts will discuss the drug at a public meeting Thursday before voting on whether to recommend its approval. Allen Breed AP

FDA panel backs Raleigh company’s female libido pill with safety conditions

June 04, 2015 4:41 PM

More Videos

  • Tesla Superchargers are coming to Raleigh. Elon Musk explains.

    Elon Musk, CEO of Tesla Inc., explains how the Tesla Supercharger, available soon in Raleigh, charges fast, extending the range of Tesla electric cars.